The Europe Hysterectomy Device Market should witness market growth of 4.9% CAGR during the forecast period (2022-2028).
Surgery may be the only option if the patient's uterus is the source of constant pelvic pain. However, some types of pelvic pain are not resolved by a hysterectomy. In addition, a hysterectomy that is not necessary could lead to additional issues. Some people elect hysterectomies, which remove the uterus and cervix, to match their bodies with their gender identities better. Removing the ovaries and fallopian tubes is another possibility with this kind of surgery. Patients are no longer able to become pregnant after a hysterectomy.
So, It is advised to ask the doctor about alternate treatment options if the patient wishes to get pregnant in the future. A hysterectomy can be the only option if the patient has cancer. Yet, there might be alternative therapies for problems such as uterine prolapse, endometriosis, and fibroids. Removing both ovaries results in surgical menopause if one is still getting periods. Menopause symptoms often appear shortly after undergoing surgical menopause. Hormone treatment used briefly can help one feel better from problems genuinely bothering the patient.
Germany has one of the world's biggest medical technology industries and, by far, the largest industry in Europe. According to the Federal Ministry for Economic Affairs and Climate Action of Germany, the German medical device sector, which accounts for about USD 35.8 billion annually or 25.6% of the entire European market, is one of the most profitable healthcare industries in the world. Germany has a robust healthcare system, particularly regarding hospital beds, infrastructure, and skilled personnel. The healthcare industry's economic impact in Germany is EUR 678.2 billion (USD 798 billion), or around 12% of Germany's GDP. This will surge the market expansion of hysterectomy devices in Europe.
The Germany market dominated the Europe Hysterectomy Device Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $29.2 million by 2028. The UK market is anticipated to grow at a CAGR of 4.1% during (2022-2028). Additionally, The France market would exhibit a CAGR of 5.7% during (2022-2028).
Based on Disease Type, the market is segmented into Chronic Pelvic Pain, Fibroids, Uterine Cancer and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Surgical Approach, the market is segmented into Abdominal Hysterectomy, Laparoscopic Hysterectomy, Robotic-assisted Laparoscopic Hysterectomy and Vaginal Hysterectomy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, B. Braun Melsungen AG, ConMed Corporation, Johnson & Johnson, Richard Wolf GmbH, Karl Storz SE & Co. KG, The Cooper Companies, Inc., Laborie Medical Technologies (Patricia Industries) (Investor AB), Fortimedix Surgical B.V., and Conkin Surgical Instruments Ltd.
Surgery may be the only option if the patient's uterus is the source of constant pelvic pain. However, some types of pelvic pain are not resolved by a hysterectomy. In addition, a hysterectomy that is not necessary could lead to additional issues. Some people elect hysterectomies, which remove the uterus and cervix, to match their bodies with their gender identities better. Removing the ovaries and fallopian tubes is another possibility with this kind of surgery. Patients are no longer able to become pregnant after a hysterectomy.
So, It is advised to ask the doctor about alternate treatment options if the patient wishes to get pregnant in the future. A hysterectomy can be the only option if the patient has cancer. Yet, there might be alternative therapies for problems such as uterine prolapse, endometriosis, and fibroids. Removing both ovaries results in surgical menopause if one is still getting periods. Menopause symptoms often appear shortly after undergoing surgical menopause. Hormone treatment used briefly can help one feel better from problems genuinely bothering the patient.
Germany has one of the world's biggest medical technology industries and, by far, the largest industry in Europe. According to the Federal Ministry for Economic Affairs and Climate Action of Germany, the German medical device sector, which accounts for about USD 35.8 billion annually or 25.6% of the entire European market, is one of the most profitable healthcare industries in the world. Germany has a robust healthcare system, particularly regarding hospital beds, infrastructure, and skilled personnel. The healthcare industry's economic impact in Germany is EUR 678.2 billion (USD 798 billion), or around 12% of Germany's GDP. This will surge the market expansion of hysterectomy devices in Europe.
The Germany market dominated the Europe Hysterectomy Device Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $29.2 million by 2028. The UK market is anticipated to grow at a CAGR of 4.1% during (2022-2028). Additionally, The France market would exhibit a CAGR of 5.7% during (2022-2028).
Based on Disease Type, the market is segmented into Chronic Pelvic Pain, Fibroids, Uterine Cancer and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Surgical Approach, the market is segmented into Abdominal Hysterectomy, Laparoscopic Hysterectomy, Robotic-assisted Laparoscopic Hysterectomy and Vaginal Hysterectomy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, B. Braun Melsungen AG, ConMed Corporation, Johnson & Johnson, Richard Wolf GmbH, Karl Storz SE & Co. KG, The Cooper Companies, Inc., Laborie Medical Technologies (Patricia Industries) (Investor AB), Fortimedix Surgical B.V., and Conkin Surgical Instruments Ltd.
Scope of the Study
By Disease Type
- Chronic Pelvic Pain
- Fibroids
- Uterine Cancer
- Others
By End-user
- Hospitals
- Ambulatory Surgical Centers
- Others
By Surgical Approach
- Abdominal Hysterectomy
- Laparoscopic Hysterectomy
- Robotic-assisted Laparoscopic Hysterectomy
- Vaginal Hysterectomy
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- B.Braun Melsungen AG
- ConMed Corporation
- Johnson & Johnson
- Richard Wolf GmbH
- Karl Storz SE & Co. KG
- The Cooper Companies, Inc.
- Laborie Medical Technologies ( Patricia Industries)(Investor AB)
- Fortimedix Surgical B.V.
- Conkin Surgical Instruments Ltd
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Europe Hysterectomy Device Market by Disease Type
Chapter 5. Europe Hysterectomy Device Market by End-user
Chapter 6. Europe Hysterectomy Device Market by Surgical Approach
Chapter 7. Europe Hysterectomy Device Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Medtronic PLC
- B. Braun Melsungen AG
- ConMed Corporation
- Johnson & Johnson
- Richard Wolf GmbH
- Karl Storz SE & Co. KG
- The Cooper Companies, Inc.
- Laborie Medical Technologies ( Patricia Industries)(Investor AB)
- Fortimedix Surgical B.V.
- Conkin Surgical Instruments Ltd
Methodology
LOADING...
Related Reports
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
